Source: Eur Respir Rev 2013; 22: 72-74
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Stuart Elborn. The impact of personalised therapies on respiratory medicine. Eur Respir Rev 2013; 22: 72-74

Member's Comments

No comment yet.

Related content which might interest you: The future of personalised medicine in COPD Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 Personalised medicine in asthma: from curative to preventive medicine Source: Eur Respir Rev 2017; 26: 160010 Year: 2017 What is evidence-based medicine? Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP) Year: 2006 The clinical benefit of personalised medicine in lung cancer Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms Year: 2014 A personalised medicine approach to ICS use in COPD Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Personalised medicine for cystic fibrosis: treating the basic defect Source: Eur Respir Rev 2013; 22: 3-5 Year: 2013 Biomarkers and personalised medicine for asthma Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018 Year: 2019 Advanced cell culture techniques and personalised medicine for cystic fibrosis Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis Source: Eur Respir J, 51 (6) 1702457; 10.1183/13993003.02457-2017 Year: 2018 Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021 Year: 2021 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Current insights and potential benefits for effective teaching and learning in respiratory medicine Source: Breathe 2012; 9: 15-24 Year: 2012 Is cystic fibrosis the hemi-neglected part of respiratory medicine? Source: Virtual Congress 2021 – CCC Thoracic oncology Year: 2021 Palliative medicine services for those with chronic lung disease Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 Personalised medicine in interstitial lung diseases Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017 Year: 2018 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020